Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Munn

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
The Journal of Biological Chemistry|December 30, 2010
Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic stateAicha Jrad-Lamine, Joelle Henry-Berger, Pascal Gourbeyre, et al.
Immunity|January 19, 2018
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c<sup>+</sup>CD103<sup>+</sup> Monocytic Antigen-Presenting Cells in TumorsMadhav D Sharma, Paulo C Rodriguez, Brent H Koehn, et al.
Journal for Immunotherapy of Cancer|July 24, 2014
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastomaMinghui Li, Aaron R Bolduc, Md Nasrul Hoda, et al.
Blood|September 14, 2013
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethalityAsim Saha, Kazutoshi Aoyama, Patricia A Taylor, et al.
Immunity|October 6, 2021
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunityMadhav D Sharma, Rafal Pacholczyk, Huidong Shi, et al.
Nature Communications|August 17, 2019
Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Blood|July 8, 2016
Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent mannerCameron McDonald-Hyman, Ryan Flynn, Angela Panoskaltsis-Mortari, et al.
Nature Communications|March 22, 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.
Cancer Cell|March 7, 2025
Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33Sara Lamorte, Rene Quevedo, Robbie Jin, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Biological Chemistry|December 30, 2010
Deficient tryptophan catabolism along the kynurenine pathway reveals that the epididymis is in a unique tolerogenic stateAicha Jrad-Lamine, Joelle Henry-Berger, Pascal Gourbeyre, et al.
Immunity|January 19, 2018
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c<sup>+</sup>CD103<sup>+</sup> Monocytic Antigen-Presenting Cells in TumorsMadhav D Sharma, Paulo C Rodriguez, Brent H Koehn, et al.
Journal for Immunotherapy of Cancer|July 24, 2014
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastomaMinghui Li, Aaron R Bolduc, Md Nasrul Hoda, et al.
Blood|September 14, 2013
Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethalityAsim Saha, Kazutoshi Aoyama, Patricia A Taylor, et al.
Immunity|October 6, 2021
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunityMadhav D Sharma, Rafal Pacholczyk, Huidong Shi, et al.
Nature Communications|August 17, 2019
Publisher Correction: ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Blood|July 8, 2016
Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent mannerCameron McDonald-Hyman, Ryan Flynn, Angela Panoskaltsis-Mortari, et al.
Nature Communications|March 22, 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repressionYu Cao, Jimena Trillo-Tinoco, Rosa A Sierra, et al.
Science Immunology|December 15, 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironmentMarie Jo Halaby, Kebria Hezaveh, Sara Lamorte, et al.
Cancer Cell|March 7, 2025
Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33Sara Lamorte, Rene Quevedo, Robbie Jin, et al.
Pageof 18